Association of HLA-A*3303-B*4403-DRB1*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population

Genes and Immunity

Volumn 3, Issue 8, 2002, Pages 477-481

  Sato, M ^a,b,c   Ohashi, J ^b   Tsuchiya, N ^b   Kashiwase, K ^a   Ishikawa, Y ^a   Arita, H ^c   Hanaoka, K ^c   Tokunaga, K ^b   Yabe, T ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

HLA haplotype; NKp30; Postherpetic neuralgia; TNFA; Varicella zoster virus

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA DR ANTIGEN; MEMBRANE RECEPTOR; PROTEIN NATURAL KILLER CELL ACTIVATING RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HLA A33, SUBTYPE A 3303; HLA B44 ANTIGEN; HLA-A33, SUBTYPE A-3303; HLA-B44; HLA-DRB1 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; NCR3 PROTEIN, HUMAN;

ARTICLE; ASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC ASSOCIATION; HAPLOTYPE; HLA SYSTEM; HUMAN; PATHOGENESIS; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROMOTER REGION; VARICELLA ZOSTER VIRUS; ADULT; AGED; COMPARATIVE STUDY; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETICS; HERPES ZOSTER; IMMUNOLOGY; JAPAN; MALE; METABOLISM; NATURAL KILLER CELL; NEURALGIA; VIROLOGY;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

ADULT; AGED; FEMALE; HAPLOTYPES; HERPES ZOSTER; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; KILLER CELLS, NATURAL; LINKAGE (GENETICS); MALE; NEURALGIA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842856259     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6363890     Document Type: Article

References (30)

1. Cluff RS, Rowbotham MC. Pain caused by herpes zoster infection. Neurol Clin 1998; 16: 813-832.
2. Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986; 20: 651-664.
3. Abendroth A, Arvin A. Varicella-zoster virus immune evasion. Immunol Rev 1999; 168: 143-156.
4. Gilden DH, Rozenman Y, Murray R, Devlin M, Vafai A. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann Neurol 1987; 22: 377-380.
5. Mainka C, Fuss B, Geiger H, Hofelmayr H, Wolff MH. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 1998; 56: 91-98.
6. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 1980; 30: 582-587.
7. Vafai A, Wellish M, Gilden DH. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci USA 1988; 85: 2767-2770.
8. Schmader K. Postherpetic neuralgia in immunocompetent elderly people. Vaccine 1998; 16: 1768-1770.
9. Dworkin RH, Boon RJ, Griffin DR, Phung D. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998; 178 (Suppl 1): S76-S80.
10. Ozawa A, Sasao Y, Iwashita K et al. HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN). Tissue Antigens 1999; 53: 263-268.
11. Tokunaga K, Ishikawa Y, Ogawa A et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997; 46: 199-205.
12. Knight JC, Udalova I, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
13. Tsuchiya N, Kawasaki A, Tsao BP et al. Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001; 2: 317-322.
14. Matsushita M, Tsuchiya N, Nakayama T et al. Allele typing of human TNFA 5′-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese. Tissue Antigens 1999; 54: 478-484.
15. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun 2000; 1: 351-357.
16. Shibue T, Tsuchiya N, Komata T et al. Tumor necrosis factor alpha 5′-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 753-757.
17. Hohjoh H, Tokunaga K. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2001; 2: 105-109.
18. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605-612.
19. Ihara T, Kamiya H, Starr SE, Arbeter AM, Lange B. Natural killing of varicella-zoster virus (VZV)-infected fibroblasts in normal children, children with VZV infections, and children with Hodgkin's disease. Acta Paediatr Jpn 1989; 31: 523-528.
20. Terada K, Kawano S, Yoshihiro K, Morita T. Natural killer cell activity in herpes zoster in children without underlying disease. Scand J Infect Dis 1993; 25: 521-524.
21. Lee SH, Girard S, Macina D et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001; 28: 42-45.
22. Brown G, Dokun AO, Heusel JW et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001; 292: 934-937.
23. Ferlazzo G, Tsang ML, Moretta L et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195: 343-351.
24. Sato M, Ohashi J, Tsuchiya N et al. Identification of novel single nucleotide substitutions in the NKp30 gene expressed in human natural killer cells. Tissue Antigens 2001; 58: 255-258.
25. Thomee R, Grimby G, Wright BD, Linacre JM. Rasch analysis of Visual Analog Scale measurements before and after treatment of patellofemoral pain syndrome in women. Scand J Rehab Med 1995; 27: 145-151.
26. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1955; 20: 309-311.
27. Tanaka H, Akaza T, Juji T. Report of the Japanese Central Bone Marrow Data Center. In: Cecka JM, Terasaki PI, (eds). CLINICAL TRANSPLANTS. UCLA Tissue Typing Laboratory, 1996, pp. 139-144.
28. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji K, Aizawa M, Sasazuki T, (eds). HLA 1991 Proceedings of the 11th International Histocompatibility Workshop and Conference. Vol. 1. Oxford Science Publications: Oxford, 1992, pp. 76-79.
29. Kato N, Kikuchi A, Kano K, Egawa K, Takiguchi M. Molecular analysis of a novel HLA-A33 subtype associated with HLA-B44. Tissue Antigens 1993; 41: 211-213.
30. Kawai S, Maekawajiri S, Tokunaga K et al. Routine low and high resolution typing of the HLA-DRB gene using the PCR-MPH (microtitre plate hybridization) method. Eur J Immunogenet 1996; 23: 471-486.